Utility of urine and serum lateral flow assays to determine the prevalence and predictors of cryptococcal antigenemia in HIV-positive outpatients beginning antiretroviral therapy in Mwanza, Tanzania
about
Lateral flow assaysPoint of Care Testing for the Diagnosis of Fungal Infections: Are We There Yet?Preventing Cryptococcosis-Shifting the Paradigm in the Era of Highly Active Antiretroviral TherapyPreheating of urine improves the specificity of urinary cryptococcal antigen testing using the lateral flow assay.Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014.Cryptococcal Meningitis: Diagnosis and Management Update.Estimated Prevalence of Cryptococcus Antigenemia (CrAg) among HIV-Infected Adults with Advanced Immunosuppression in Namibia Justifies Routine Screening and Preemptive Treatment.Six-month outcomes of HIV-infected patients given short-course fluconazole therapy for asymptomatic cryptococcal antigenemia.Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort StudyCryptococcal Antigenemia in Nigerian Patients With Advanced Human Immunodeficiency Virus: Influence of Antiretroviral Therapy AdherenceThe cryptococcal antigen lateral flow assay: A point-of-care diagnostic at an opportune time.Brief Report: Geographical Variation in Prevalence of Cryptococcal Antigenemia Among HIV-Infected, Treatment-Naive Patients in Nigeria: A Multicenter Cross-Sectional StudyBurden of serious fungal infections in Tanzania.The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).Cryptococcal antigen screening by lay cadres using a rapid test at the point of care: A feasibility study in rural Lesotho.Enzyme-linked immunosorbent assays (ELISA) based on thread, paper, and fabric.HIV-Associated Cryptococcal Disease in Resource-Limited Settings: A Case for "Prevention Is Better Than Cure"?Performance of cryptococcal antigen lateral flow assay in serum, cerebrospinal fluid, whole blood, and urine in HIV-infected patients with culture-proven cryptococcal meningitis admitted at a Brazilian referral center.CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis.Poor specificity of urinary cryptococcal antigen testing: Reply to Drain et al. Prevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu-Natal.History of ZIKV Infections in India and Management of Disease Outbreaks
P2860
Q26745852-EDFFA555-5018-4B80-AF10-BF5C09872BD3Q26746020-E03D707A-97FB-4B43-8B77-364A13EA2C2FQ26994750-58F02A47-901E-44D9-A681-952F0AAAD11FQ33663275-632FDB0B-9425-453F-AF5B-9B00D4BF5098Q33777533-A2CE9320-0E63-4499-A6E8-E30D30536F4AQ35951094-2479D59E-F267-4D95-8940-F02080A373DAQ36167708-23F6D62A-63EB-4651-8317-0C934AA06B7CQ36277675-C8CCB9B7-A6AF-4A15-B8DA-D2D3182CD14CQ36543833-1ACD7D1C-C8A1-463D-AF4B-59A5E55407DDQ36900055-1CFEB57D-44B1-42FC-8A01-ECD85B586422Q38328870-229665EA-9860-4C1E-810C-E65421624DB4Q38380494-C259A38B-6B63-4A35-9D1A-E2549208140FQ38997873-D66FF2BE-1DB9-4DCC-98B2-5B792B051594Q39189670-C6324EB9-D850-4CBF-8510-ADDF6D6885EAQ40055779-C0B67A93-046E-4A5C-8F5C-A5BA18BCA52BQ46937942-3DF122A2-80E7-47D0-997A-24DCB255ABA2Q47646979-A66ADE11-8181-43A2-A5F5-AA3D2218A46DQ49931177-63DF940C-616F-4E4D-A1DE-0DAEF68DE874Q51365549-6BB5D09E-92FB-4D88-99FC-88223797653CQ51367854-7EEE290E-2F72-4938-AFBA-A8A0C9C88530Q56909500-65CBDD03-077A-4C59-93D3-75FC6A711EEA
P2860
Utility of urine and serum lateral flow assays to determine the prevalence and predictors of cryptococcal antigenemia in HIV-positive outpatients beginning antiretroviral therapy in Mwanza, Tanzania
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Utility of urine and serum lat ...... al therapy in Mwanza, Tanzania
@ast
Utility of urine and serum lat ...... al therapy in Mwanza, Tanzania
@en
Utility of urine and serum lat ...... al therapy in Mwanza, Tanzania
@nl
type
label
Utility of urine and serum lat ...... al therapy in Mwanza, Tanzania
@ast
Utility of urine and serum lat ...... al therapy in Mwanza, Tanzania
@en
Utility of urine and serum lat ...... al therapy in Mwanza, Tanzania
@nl
prefLabel
Utility of urine and serum lat ...... al therapy in Mwanza, Tanzania
@ast
Utility of urine and serum lat ...... al therapy in Mwanza, Tanzania
@en
Utility of urine and serum lat ...... al therapy in Mwanza, Tanzania
@nl
P2093
P2860
P356
P1476
Utility of urine and serum lat ...... al therapy in Mwanza, Tanzania
@en
P2093
Awilly A Chofle
Jeremiah Seni
Kinanga A Magambo
Samuel E Kalluvya
Shikha W Kapoor
P2860
P356
10.7448/IAS.17.1.19040
P577
2014-08-08T00:00:00Z